Skip to main content
Erschienen in: Brain Tumor Pathology 3/2023

05.06.2023 | Original Article

α-SMA positive vascular mural cells suppress cyst formation in hemangioblastoma

verfasst von: Maki Sakaguchi, Riho Nakajima, Toshiya Ichinose, Shingo Tanaka, Ryouken Kimura, Hemragul Sabit, Satoko Nakada, Mitsutoshi Nakada

Erschienen in: Brain Tumor Pathology | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Approximately 60% of hemangioblastomas (HBs) have peritumoral cysts adjacent to the tumor, which can cause neurological deficits due to the mass effect, and the management of cyst formation is a clinical challenge. Vascular mural cells surrounding endothelial cells consist of vascular smooth muscle cells (vSMCs) and pericytes, which are essential elements that support blood vessels and regulate permeability. This study investigated the involvement of mural cells in cyst formation. We analyzed the expression of α-smooth muscle actin (α-SMA), platelet-derived growth factor receptor-beta (PDGFRB), and CD31 in 39 consecutive human cerebellar HBs, 20 of cystic and 19 of solid type. Solid type HBs showed stronger diffuse expression of α-SMA in precapillary arterioles and capillaries within the tumor than cystic type HBs (p = 0.001), whereas there was no difference in PDGFRB and CD31 expression. Detailed observation with immunofluorescence demonstrated that α-SMA was expressed in vascular mural cells surrounding capillaries in the solid rather than in the cystic type. Multivariate analysis including various clinical and pathological factors showed that lower α-SMA expression was significantly correlated with cyst formation (p < 0.001). Our data suggested that vascular mural cells from precapillary arterioles to capillaries expressing α-SMA may be pericytes and play a crucial role in HB cystogenesis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Huntoon K, Wu T, Elder JB et al (2016) Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel-Lindau disease. J Neurosurg 124:971–976CrossRefPubMed Huntoon K, Wu T, Elder JB et al (2016) Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel-Lindau disease. J Neurosurg 124:971–976CrossRefPubMed
3.
Zurück zum Zitat Wanebo JE, Lonser RR, Glenn GM et al (2003) The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 98:82–94CrossRefPubMed Wanebo JE, Lonser RR, Glenn GM et al (2003) The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 98:82–94CrossRefPubMed
4.
Zurück zum Zitat Lonser RR, Vortmeyer AO, Butman JA et al (2005) Edema is a precursor to central nervous system peritumoral cyst formation. Ann Neurol 58:392–399CrossRefPubMed Lonser RR, Vortmeyer AO, Butman JA et al (2005) Edema is a precursor to central nervous system peritumoral cyst formation. Ann Neurol 58:392–399CrossRefPubMed
5.
Zurück zum Zitat Gläsker S, Vortmeyer AO, Lonser RR et al (2006) Proteomic analysis of hemangioblastoma cyst fluid. Cancer Biol Ther 5:549–553CrossRefPubMed Gläsker S, Vortmeyer AO, Lonser RR et al (2006) Proteomic analysis of hemangioblastoma cyst fluid. Cancer Biol Ther 5:549–553CrossRefPubMed
6.
Zurück zum Zitat Armulik A, Genové G, Mäe M et al (2010) Pericytes regulate the blood-brain barrier. Nature 468:557–561CrossRefPubMed Armulik A, Genové G, Mäe M et al (2010) Pericytes regulate the blood-brain barrier. Nature 468:557–561CrossRefPubMed
7.
Zurück zum Zitat Mäe MA, He L, Nordling S et al (2021) Single-cell analysis of blood-brain barrier response to pericyte loss. Circ Res 128:e46–e62CrossRefPubMed Mäe MA, He L, Nordling S et al (2021) Single-cell analysis of blood-brain barrier response to pericyte loss. Circ Res 128:e46–e62CrossRefPubMed
9.
Zurück zum Zitat Smyth LCD, Rustenhoven J, Scotter EL et al (2018) Markers for human brain pericytes and smooth muscle cells. J Chem Neuroanat 92:48–60CrossRefPubMed Smyth LCD, Rustenhoven J, Scotter EL et al (2018) Markers for human brain pericytes and smooth muscle cells. J Chem Neuroanat 92:48–60CrossRefPubMed
10.
Zurück zum Zitat Alarcon-Martinez L, Yemisci M, Dalkara T (2021) Pericyte morphology and function. Histol Histopathol 36:633–643PubMed Alarcon-Martinez L, Yemisci M, Dalkara T (2021) Pericyte morphology and function. Histol Histopathol 36:633–643PubMed
11.
Zurück zum Zitat Damisah EC, Hill RA, Tong L et al (2017) A fluoro-Nissl dye identifies pericytes as distinct vascular mural cells during in vivo brain imaging. Nat Neurosci 20:1023–1032CrossRefPubMedPubMedCentral Damisah EC, Hill RA, Tong L et al (2017) A fluoro-Nissl dye identifies pericytes as distinct vascular mural cells during in vivo brain imaging. Nat Neurosci 20:1023–1032CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Vanlandewijck M, He L, Mäe MA et al (2018) A molecular atlas of cell types and zonation in the brain vasculature. Nature 554:475–480CrossRefPubMed Vanlandewijck M, He L, Mäe MA et al (2018) A molecular atlas of cell types and zonation in the brain vasculature. Nature 554:475–480CrossRefPubMed
13.
Zurück zum Zitat Grant RI, Hartmann DA, Underly RG et al (2019) Organizational hierarchy and structural diversity of microvascular pericytes in adult mouse cortex. J Cereb Blood Flow Metab 39:411–425CrossRefPubMed Grant RI, Hartmann DA, Underly RG et al (2019) Organizational hierarchy and structural diversity of microvascular pericytes in adult mouse cortex. J Cereb Blood Flow Metab 39:411–425CrossRefPubMed
14.
Zurück zum Zitat Chasseigneaux S, Moraca Y, Cochois-Guégan V et al (2018) Isolation and differential transcriptome of vascular smooth muscle cells and mid-capillary pericytes from the rat brain. Sci Rep 8:12272CrossRefPubMedPubMedCentral Chasseigneaux S, Moraca Y, Cochois-Guégan V et al (2018) Isolation and differential transcriptome of vascular smooth muscle cells and mid-capillary pericytes from the rat brain. Sci Rep 8:12272CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Bohannon DG, Long D, Kim WK (2021) Understanding the heterogeneity of human pericyte subsets in blood-brain barrier homeostasis and neurological diseases. Cells 10:890CrossRefPubMedPubMedCentral Bohannon DG, Long D, Kim WK (2021) Understanding the heterogeneity of human pericyte subsets in blood-brain barrier homeostasis and neurological diseases. Cells 10:890CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Almaça J, Weitz J, Rodriguez-Diaz R et al (2018) The pericyte of the pancreatic islet regulates capillary diameter and local blood flow. Cell Metab 27:630-644.e4CrossRefPubMedPubMedCentral Almaça J, Weitz J, Rodriguez-Diaz R et al (2018) The pericyte of the pancreatic islet regulates capillary diameter and local blood flow. Cell Metab 27:630-644.e4CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Dubrac A, Künzel SE, Künzel SH et al (2018) NCK-dependent pericyte migration promotes pathological neovascularization in ischemic retinopathy. Nat Commun 9:3463CrossRefPubMedPubMedCentral Dubrac A, Künzel SE, Künzel SH et al (2018) NCK-dependent pericyte migration promotes pathological neovascularization in ischemic retinopathy. Nat Commun 9:3463CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Morikawa S, Baluk P, Kaidoh T et al (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160:985–1000CrossRefPubMedPubMedCentral Morikawa S, Baluk P, Kaidoh T et al (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160:985–1000CrossRefPubMedPubMedCentral
19.
20.
Zurück zum Zitat Natarajan V, Ha S, Delgado A et al (2022) Acquired αSMA Expression in pericytes coincides with aberrant vascular structure and function in pancreatic ductal adenocarcinoma. Cancers (Basel) 14:2448CrossRefPubMed Natarajan V, Ha S, Delgado A et al (2022) Acquired αSMA Expression in pericytes coincides with aberrant vascular structure and function in pancreatic ductal adenocarcinoma. Cancers (Basel) 14:2448CrossRefPubMed
21.
Zurück zum Zitat Hasselblatt M, Jeibmann A, Gerss J et al (2005) Cellular and reticular variants of haemangioblastoma revisited: a clinicopathologic study of 88 cases. Neuropathol Appl Neurobiol 31:618–622CrossRefPubMed Hasselblatt M, Jeibmann A, Gerss J et al (2005) Cellular and reticular variants of haemangioblastoma revisited: a clinicopathologic study of 88 cases. Neuropathol Appl Neurobiol 31:618–622CrossRefPubMed
22.
Zurück zum Zitat Hartmann DA, Underly RG, Grant RI et al (2015) Pericyte structure and distribution in the cerebral cortex revealed by high-resolution imaging of transgenic mice. Neurophotonics 2:041402CrossRefPubMedPubMedCentral Hartmann DA, Underly RG, Grant RI et al (2015) Pericyte structure and distribution in the cerebral cortex revealed by high-resolution imaging of transgenic mice. Neurophotonics 2:041402CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Tadeo I, Bueno G, Berbegall AP et al (2016) Vascular patterns provide therapeutic targets in aggressive neuroblastic tumors. Oncotarget 7:19935–19947CrossRefPubMedPubMedCentral Tadeo I, Bueno G, Berbegall AP et al (2016) Vascular patterns provide therapeutic targets in aggressive neuroblastic tumors. Oncotarget 7:19935–19947CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Baccala A, Sercia L, Li J et al (2007) Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms. Urology 70:385–390CrossRefPubMed Baccala A, Sercia L, Li J et al (2007) Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms. Urology 70:385–390CrossRefPubMed
26.
Zurück zum Zitat Bohannon DG, Okhravi HR, Kim J et al (2020) A subtype of cerebrovascular pericytes is associated with blood-brain barrier disruption that develops during normal aging and simian immunodeficiency virus infection. Neurobiol Aging 96:128–136CrossRefPubMedPubMedCentral Bohannon DG, Okhravi HR, Kim J et al (2020) A subtype of cerebrovascular pericytes is associated with blood-brain barrier disruption that develops during normal aging and simian immunodeficiency virus infection. Neurobiol Aging 96:128–136CrossRefPubMedPubMedCentral
27.
28.
Zurück zum Zitat von Tell D, Armulik A, Betsholtz C (2006) Pericytes and vascular stability. Exp Cell Res 312:623–629CrossRef von Tell D, Armulik A, Betsholtz C (2006) Pericytes and vascular stability. Exp Cell Res 312:623–629CrossRef
29.
Zurück zum Zitat Zambach SA, Cai C, Helms HCC et al (2021) Precapillary sphincters and pericytes at first-order capillaries as key regulators for brain capillary perfusion. Proc Natl Acad Sci U S A 118:e2023749118CrossRefPubMedPubMedCentral Zambach SA, Cai C, Helms HCC et al (2021) Precapillary sphincters and pericytes at first-order capillaries as key regulators for brain capillary perfusion. Proc Natl Acad Sci U S A 118:e2023749118CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Goel S, Wong AH, Jain RK (2012) Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease. Cold Spring Harb Perspect Med 2:a006486CrossRefPubMedPubMedCentral Goel S, Wong AH, Jain RK (2012) Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease. Cold Spring Harb Perspect Med 2:a006486CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58–62CrossRefPubMed Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58–62CrossRefPubMed
33.
Zurück zum Zitat Li B, Xu D, Zhou J et al (2022) Monitoring bevacizumab-induced tumor vascular normalization by intravoxel incoherent motion diffusion-weighted MRI. J Magn Reson Imaging 56:427–439CrossRefPubMed Li B, Xu D, Zhou J et al (2022) Monitoring bevacizumab-induced tumor vascular normalization by intravoxel incoherent motion diffusion-weighted MRI. J Magn Reson Imaging 56:427–439CrossRefPubMed
34.
Zurück zum Zitat Hauge A, Gaustad JV, Huang R et al (2019) DCE-MRI and quantitative histology reveal enhanced vessel maturation but impaired perfusion and increased hypoxia in bevacizumab-treated cervical carcinoma. Int J Radiat Oncol Biol Phys 104:666–676CrossRefPubMed Hauge A, Gaustad JV, Huang R et al (2019) DCE-MRI and quantitative histology reveal enhanced vessel maturation but impaired perfusion and increased hypoxia in bevacizumab-treated cervical carcinoma. Int J Radiat Oncol Biol Phys 104:666–676CrossRefPubMed
35.
Zurück zum Zitat Vangestel C, Van de Wiele C, Van Damme N et al (2011) (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab. J Nucl Med 52:1786–1794CrossRefPubMed Vangestel C, Van de Wiele C, Van Damme N et al (2011) (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab. J Nucl Med 52:1786–1794CrossRefPubMed
36.
Zurück zum Zitat Okamoto S, Nitta M, Maruyama T et al (2016) Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas. Brain Tumor Pathol 33:129–136CrossRefPubMed Okamoto S, Nitta M, Maruyama T et al (2016) Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas. Brain Tumor Pathol 33:129–136CrossRefPubMed
Metadaten
Titel
α-SMA positive vascular mural cells suppress cyst formation in hemangioblastoma
verfasst von
Maki Sakaguchi
Riho Nakajima
Toshiya Ichinose
Shingo Tanaka
Ryouken Kimura
Hemragul Sabit
Satoko Nakada
Mitsutoshi Nakada
Publikationsdatum
05.06.2023
Verlag
Springer Nature Singapore
Erschienen in
Brain Tumor Pathology / Ausgabe 3/2023
Print ISSN: 1433-7398
Elektronische ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-023-00465-6

Weitere Artikel der Ausgabe 3/2023

Brain Tumor Pathology 3/2023 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.